Skip to content
Genesis Innovation Group
Menu
  • Home
  • About Us
  • Device Development
  • Investing
  • News
  • Contact Us

Category: News

OMTEC 2019 Rob Ball
News

Rob Ball – Keynote Panelist at OMTEC 2019

Rob Ball, CEO of Genesis Innovation Group will be a Keynote Panelist at OMTEC 2019.

shoulder innovations genesis news
News / Press Release

Shoulder Innovations Announces Publication of Long Term Data for InSet Glenoid

HOLLAND, Mich., April 18th, 2019—Genesis Innovation Group’s Shoulder Innovations (SI) is focused on human centered design.

HAPPE Spine news
News / Press Release

cultivate(MD) Announces Investment Into HAPPE Spine

HOLLAND, Mich., April 11, 2019 — Genesis Innovation Group and their cultivate(MD) Capital Fund I and cultivate(MD) Seed Fund, funds focused on investments into early-stage healthcare companies with innovative technologies, …

culitvate md news
News / Press Release

cultivate(MD) Announces Investment Into Embody, Inc.

HOLLAND, Mich., March 4th, 2019– Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its investment into Embody, Inc.

2019-asap-meeting-genesis
News

ASAP Meeting Workshop

Genesis will be hosting a special Workshop at the 2019 ASAP Meeting.

grand rapids business journal cultivate md
News

VC fund invests in medical software startup – Grand Rapids Business Journal

A venture capital fund in the region has invested in a medical startup on the state’s east side.

grand rapids business journal cultivate md
News

VC fund invests in medical device startup – Grand Rapids Business Journal

A venture capital fund in the region focused on early stage health care companies with innovative technologies has made a new out-of-state investment.

culitvate md news
News / Press Release

cultivate(MD) Announces Investment Into Medical Ingenuities, LLC.

HOLLAND, Mich., November 20th, 2018—Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments in early-stage healthcare companies with innovative technologies, announces its investment into Medical Ingenuities, LLC.

shoulder innovations genesis news
News / Press Release

Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology

HOLLAND, Mich., Nov. 5, 2018 /PRNewswire/ — Shoulder Innovations announced today that they have received FDA clearance for their InSet Humeral Short Stem System.  This is a key addition to …

culitvate md news
News / Press Release

cultivate(MD) Funds Announces Investment Into HAPPE Spine

HOLLAND, Mich., July 19, 2018— Genesis Innovation Group, LLC, announces the formation of HAPPE Spine LLC as well as investments by cultivate(MD) Capital Fund I, LLC and cultivate(MD) Seed Fund …

Posts navigation

Older posts
Newer posts

Latest News

  • Medical Ingenuities Receives FDA 510(k) Clearance for PH Band
  • An Interview with E. Mark Haacke, Ph.D.
  • SafKan Health Announces FDA 510(k) Clearance for First-of-its-Kind OtoSet™ Ear Cleaning System
  • Holland medical device developer raises more than $21M in capital round
  • Shoulder Innovations Announces Equity Financing of $21.6M
cultivatemd medical device venture capital wmt exit

Genesis Services

  • Medical Device Development
  • Engineering
  • Regulatory
  • Operations
  • Finance
  • Commercialization

Investing

  • For Investors
  • For Companies Seeking Investment
  • Portfolio

News & Updates

  • Medical Ingenuities Receives FDA 510(k) Clearance for PH Band
  • An Interview with E. Mark Haacke, Ph.D.
  • SafKan Health Announces FDA 510(k) Clearance for First-of-its-Kind OtoSet™ Ear Cleaning System

Contact Us

Genesis Innovation Group
13827 Port Sheldon St.
Holland, MI 49424

(616) 294-1026

Copyright © 2020 Genesis Innovation Group  
This website may contain forward-looking statements within the meaning of the relevant sections of the Securities Act. The words “believes”, “anticipates”, “expects”, “plans”, “intends” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements and statements of expectations, plans and intent are subject to a number of risks and uncertainties. Genesis Innovation Group, LLC’s actual future results may differ materially or adversely from those described in the forward-looking statements as a result of, among other things, uncertainties and other matters described in this website, generally. Genesis Innovation Group, LLC undertakes no obligation to release the results of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances. Genesis Innovation Group, LLC cautions the reader, however, that the identified uncertainties and other cautionary language contained herein may not be exhaustive. Nothing in this website shall be construed to be an offer to sell or a solicitation of an offer to purchase any particular securities. Any such offer or solicitation will be made only pursuant to definitive legal agreements prepared specifically for such purpose.